FDA’s NAM framework emphasizes context of use, human biological relevance, technical characterization, and fit-for-purpose ...

Health secretary Wes Streeting is considering expanding the existing schedule to age groups beyond infants, such as teenagers.

Congressional enactment of the most-favored nation drug pricing policy urged by President Donald Trump in his State of the Union message would gravely harm American innovation, competitiveness, and ...

A Gilead executive highlights limited investment in innovation against the need to speed up access to ATMPs.

LONDON, 05 March 2026 – GlobalData Plc, the trusted intelligence platform and parent company of Pharmaceutical Technology, today moves from AIM to the Main Market of the London Stock Exchange. The ...

Developments across the sector highlight a period of rapid acceleration and structural modernization. Welcome back to the PharmTech Weekly Roundup! I’m Susan Haigney, lead editor of PharmTech. There ...

Pharmaceutical companies in India are driving innovation, biosimilars, APIs & global exports while strengthening research, manufacturing & healthcare access.

Under this collaboration, MGI will support NUS PPS in establishing a high-performance multi-omics environment. The lab features an integrated instrument portfolio designed to provide deep insights ...

Is TEVA a good stock to buy? We came across a bullish thesis on Teva Pharmaceutical Industries Limited on Kontra ...

The global industrial sector is currently witnessing a critical shift toward ultra-fine material processing, a transformation driven by the increasing technical requirements of the pharmaceutical, new ...

GRANTS PASS, OR / ACCESS Newswire / March 16, 2026 / Venture capitalist and biotech entrepreneur Andrew Hamilton, through his investment firm Pale Horse Capital, has acquired the premium ...

Integrating high-throughput proteomics into pharmaceutical R&D has shifted how laboratories approach target identification and disease modeling. Mapping complex protein networks provides a functional ...